As of 2025-07-22, the Intrinsic Value of Kalbe Farma Tbk PT (KLBF.JK) is 975.72 IDR. This KLBF.JK valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1,505.00 IDR, the upside of Kalbe Farma Tbk PT is -35.20%.
The range of the Intrinsic Value is 845.50 - 1,169.39 IDR
Based on its market price of 1,505.00 IDR and our intrinsic valuation, Kalbe Farma Tbk PT (KLBF.JK) is overvalued by 35.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 845.50 - 1,169.39 | 975.72 | -35.2% |
| DCF (Growth 10y) | 1,012.98 - 1,359.64 | 1,153.96 | -23.3% |
| DCF (EBITDA 5y) | 1,083.38 - 1,496.00 | 1,225.28 | -18.6% |
| DCF (EBITDA 10y) | 1,223.20 - 1,684.59 | 1,390.24 | -7.6% |
| Fair Value | 440.41 - 440.41 | 440.41 | -70.74% |
| P/E | 946.51 - 1,177.05 | 1,087.29 | -27.8% |
| EV/EBITDA | 729.00 - 1,045.53 | 882.22 | -41.4% |
| EPV | 525.40 - 609.06 | 567.23 | -62.3% |
| DDM - Stable | 395.00 - 758.05 | 576.53 | -61.7% |
| DDM - Multi | 755.59 - 1,088.54 | 889.55 | -40.9% |
| Market Cap (mil) | 70,454,170.00 |
| Beta | 0.66 |
| Outstanding shares (mil) | 46,813.40 |
| Enterprise Value (mil) | 66,445,228.00 |
| Market risk premium | 7.88% |
| Cost of Equity | 12.62% |
| Cost of Debt | 5.00% |
| WACC | 12.55% |